Literature DB >> 10467267

Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus.

X Zhou1, W I Rodriguez, R A Casillas, V Ma, J Tam, Z Hu, V Lelievre, A Chao, J A Waschek.   

Abstract

It has been demonstrated that pituitary adenylate cyclase activating polypeptide (PACAP) promotes the survival of neurons in culture and can inhibit neuronal cell death after experimental injury. Furthermore, peripheral axotomy results in increased PACAP gene expression in sensory and sympathetic neurons, suggesting that PACAP might be a mediator in the injury response in certain parts of the nervous system. However, changes in PACAP expression have not been reported in injured motor neurons, despite the significant problem of motor neuron degeneration in injury and in several neurological diseases. We examined here changes in gene expression of PACAP and two high-affinity PACAP receptors, PAC(1) and VPAC(2), in adult rat motor neurons after facial nerve axotomy by in situ hybridization. PACAP gene expression was very low in facial motor neurons of normal rats. However, a robust time-dependent increase in PACAP mRNA was observed in the facial motor nucleus in most or all axotomized motor neurons. This induction was detectable 6 hr after axotomy, and peaked at 48 hr, when expression on the injured side averaged more than 20-fold higher than that on the contralateral side. Thereafter, PACAP mRNA levels decreased slightly, but remained more than 10-fold elevated for as long as 30 days after axotomy. In contrast to PACAP, gene expression for both the PAC(1) and VPAC(2) receptor was high in facial motor neurons of normal rats. No significant change was observed for VPAC(2) receptor gene expression in facial motor neurons after axotomy, whereas gene expression for the PAC(1) receptor became significantly decreased. The results indicate that the PACAP ligand receptor system is tightly regulated in the facial motor nucleus after axotomy, providing evidence that PACAP may be involved in motor injury responses. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467267

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  26 in total

1.  Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors.

Authors:  M Lee; V Lelievre; P Zhao; M Torres; W Rodriguez; J Y Byun; S Doshi; Y Ioffe; G Gupta; A E de los Monteros; J de Vellis; J Waschek
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Transient changes in spinal cord glial cells following transection of preganglionic sympathetic axons.

Authors:  Aminata P Coulibaly; Lori G Isaacson
Journal:  Auton Neurosci       Date:  2012-01-29       Impact factor: 3.145

3.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

4.  Localization and chemical coding of the dorsal motor vagal nucleus (DMX) neurons projecting to the porcine stomach prepyloric area in the physiological state and after stomach partial resection.

Authors:  Marta Gańko; Jarosław Całka
Journal:  J Mol Neurosci       Date:  2013-09-10       Impact factor: 3.444

5.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

6.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

7.  Use of laser microdissection in the investigation of facial motoneuron and neuropil molecular phenotypes after peripheral axotomy.

Authors:  Nichole A Mesnard; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  Exp Neurol       Date:  2010-06-04       Impact factor: 5.330

8.  High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons.

Authors:  Michael C Condro; Anna Matynia; Nicholas N Foster; Yukio Ago; Abha K Rajbhandari; Christina Van; Bhavaani Jayaram; Sachin Parikh; Anna L Diep; Eileen Nguyen; Victor May; Hong-Wei Dong; James A Waschek
Journal:  J Comp Neurol       Date:  2016-06-03       Impact factor: 3.215

9.  Expression of PACAP-like compounds during the caudal regeneration of the earthworm Eisenia fetida.

Authors:  Eszter Varhalmi; Ildiko Somogyi; Gabor Kiszler; Jozsef Nemeth; Dora Reglodi; Andrea Lubics; Peter Kiss; Andrea Tamas; Edit Pollak; Laszlo Molnar
Journal:  J Mol Neurosci       Date:  2008-07-12       Impact factor: 3.444

10.  Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.

Authors:  Melissa M Haulcomb; Nichole A Mesnard; Richard J Batka; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.